e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
Karen M. Olsson, Jan Fuge, Torben Brod, Jan C. Kamp, Jan Schmitto, Tibor Kempf, Johann Bauersachs, Marius M. Hoeper
Source:
Eur Respir J, 56 (5) 2000616; 10.1183/13993003.00616-2020
Journal Issue:
November
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Karen M. Olsson, Jan Fuge, Torben Brod, Jan C. Kamp, Jan Schmitto, Tibor Kempf, Johann Bauersachs, Marius M. Hoeper. Oral iron supplementation with ferric maltol in patients with pulmonary hypertension. Eur Respir J, 56 (5) 2000616; 10.1183/13993003.00616-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Iron deficiency is common in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 1386-1391
Year: 2011
Effect of zinc supplementation in children with asthma
Source: Virtual Congress 2021 – Early-life infections, wheezing and asthma
Year: 2021
Iron carboxymaltose improves exercise tolerance and right heart strain in patients with PAH and iron deficiency: A long-term pilot study
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017
High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Acute effects of oxygen supplementation during exercise in patients with pulmonary arterial hypertension
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019
Iron deficiency in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Iron deficiency in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Effect of zinc supplementation on respiratory infections in children with cystic fibrosis
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009
Effects of oxygen supplementation during pulmonary rehabilitation in COPD normoxemic patients
Source: Annual Congress 2010 - Rehabilitation: more than just exercise
Year: 2010
Efficacy of long-lasting magnesium supplementation in asthmatic children
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004
The effect of oral zinc sulphate on immune system of patients with pulmonary tuberculosis
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008
Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007
Iron deficiency in non-anemic patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD: mechanisms and biomarker
Year: 2011
The acute and chronic effects of dietry nitrate on exercise tolerance in COPD patients
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Effect of suplementary dietary antioxidants in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 428s
Year: 2006
Efficacy of antioxidant supplementation diet in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004
Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study
Source: Eur Respir J 2005; 25: 62-68
Year: 2005
BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Co-application of oxygen improves iloprost inhalation in pulmonary hypertension patients with long-term oxygen therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept